IADAPT-Third Phase
If you agree to take part in this study, you will be randomly assigned (as in the flip of a
coin) to 1 of 2 study groups:
- Group 1 will watch a DVD and receive a booklet of information about their disease type
(knee osteoarthritis, osteoporosis, or rheumatoid arthritis).
- Group 2 will read a booklet about their disease type.
All the materials including the DVD, booklet, and questionnaires will be in English and
Spanish. You may choose which language you prefer to use while watching and/or reading the
materials.
You will be asked to complete questionnaires before and after watching the DVD or reading
the booklet. We will ask you about how the material made you think and feel and how easy or
hard the material was to understand.
You will also fill out short questionnaires that include questions about your demographic
information, your health, your thoughts about bone/joint disease, how you might choose
treatments for bone/joint disease, and how you make treatment decisions. These
questionnaires will take up to 45 minutes to complete in the clinic.
This first visit will take about 60-90 minutes total to complete. If you are unable to
complete this first visit today you will need to complete it within the next two weeks.
You will be asked to fill out these questionnaires again 3 months and 6 months later, by
mail. The study staff will mail you the questionnaires, along with a postage-paid return
envelope that you can use to send the questionnaires back. If you prefer you can also
complete the questionnaires over the phone or the research staff can meet you at the clinic
or your home to complete the questionnaires at 3 and 6 months.
Your participation on this study will be over after you have mailed back the 6-month
questionnaires.
This is an investigational study.
Up to 828 participants will take part in this multicenter study.
Observational
Observational Model: Case Control, Time Perspective: Prospective
Disease Knowledge and Therapeutic Options
Primary analyses performed using repeated measures ANOVA, with group allocation - multimedia patient decision aids (MM-PtDA) vs. Comparative Effectiveness Research Summary Guide (CERSG) as the factor of interest and knowledge as the central outcome measure.
3 months
No
Angeles M. Lopez-Olivo, MD, PHD, MS
Principal Investigator
UT MD Anderson Cancer Center
United States: Institutional Review Board
2012-0172
NCT01698762
March 2013
Name | Location |
---|---|
UT MD Anderson Cancer Center | Houston, Texas 77030 |
Harris County Hospital District (HCHD) | Houston, Texas 77030 |
Kelsey-Seybold Clinic | Houston, Texas 77025 |